CRISPR/Cas9 knockout of HAS2 in rat chondrosarcoma chondrocytes demonstrates the requirement of hyaluronan for aggrecan retention.
about
What rheumatologists need to know about CRISPR/Cas9.Provisional matrix: A role for versican and hyaluronan.Changes in hyaluronan deposition in the rat myenteric plexus after experimentally-induced colitis.Genome Engineering for Personalized Arthritis Therapeutics.The pericellular hyaluronan of articular chondrocytes.A novel mouse model of intervertebral disc degeneration shows altered cell fate and matrix homeostasis.
P2860
CRISPR/Cas9 knockout of HAS2 in rat chondrosarcoma chondrocytes demonstrates the requirement of hyaluronan for aggrecan retention.
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
CRISPR/Cas9 knockout of HAS2 i ...... uronan for aggrecan retention.
@ast
CRISPR/Cas9 knockout of HAS2 i ...... uronan for aggrecan retention.
@en
type
label
CRISPR/Cas9 knockout of HAS2 i ...... uronan for aggrecan retention.
@ast
CRISPR/Cas9 knockout of HAS2 i ...... uronan for aggrecan retention.
@en
prefLabel
CRISPR/Cas9 knockout of HAS2 i ...... uronan for aggrecan retention.
@ast
CRISPR/Cas9 knockout of HAS2 i ...... uronan for aggrecan retention.
@en
P2093
P2860
P1433
P1476
CRISPR/Cas9 knockout of HAS2 i ...... uronan for aggrecan retention.
@en
P2093
Cheryl B Knudson
Emily B Askew
Warren Knudson
P2860
P356
10.1016/J.MATBIO.2016.04.002
P577
2016-04-14T00:00:00Z